A 48-year-old woman with biopsy-proven nasopharyngeal carcinoma (undifferentiated squamous cell type) is being staged for treatment planning. She is asymptomatic for distant metastases. Which investigation is most appropriate as the next step to detect occult metastatic disease and guide treatment intensity?